Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-29

FDA Approved: CURIST ALLERGY RELIEF — Original Application (Little Pharma, Inc.)

View source ↗

Summary

FDA approved Little Pharma, Inc.'s CURIST ALLERGY RELIEF as the original ANDA for levocetirizine dihydrochloride 5 mg, a generic tablet for allergy symptom reli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CURIST ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

ORIG AP for CURIST ALLERGY RELIEF (LEVOCETIRIZINE DIHYDROCHLORIDE 5 MG)